Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

First up, the location of the palmar pill recipe, because if you can make them yourself, you can have — in theory — an infinite supply. You can get the palmar pill recipe from Shadow's Whisper Cave ...

Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi. J&J hasn't announced how much Icotyde will ...

Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the lucrative psoriasis market with a new approval for a much-anticipated daily ...

The Pink Pill: Sex, Drugs and Who Has Control (now on Paramount+) has the potential to be a doozy of a Capitalism Movie. Director Aisling Chin-Yee’s documentary tells the long, winding story of ...

Will it be the best thing since sliced bread? Keto is a high-fat, moderate-protein and low-carb diet designed to plunge the body into ketosis, where it burns fat instead of carbs for fuel. Dieters ...

Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...

The FDA approved Addyi, the first pill for low libido in women, boosting sexual desire. A Paramount+ documentary follows Cindy Eckert's campaign for FDA approval off Addyi Addyi improves sexual ...

Doctors call Wegovy's new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly 200,000 people ...

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...